John Vissing

41PUBLICATIONS
247CO-AUTHORS
Gene and molecular therapyMedical mycologyCell physiologyMedical biochemistry - inorganic elements and compoundsMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (41)

|Apr 08, 2026
A Delphi consensus on integrating novel therapies into the management of generalized myasthenia gravis.

John Vissing, Fritz Zimprich, Sari Atula

|Apr 06, 2026
Quantitative Measurement of Glycosylated ⍺-Dystroglycan as a Biomarker for Disease Severity in Limb-Girdle Muscular Dystrophy Type 2I/R9.

John Vissing, Tahseen Mozaffar, Nicholas E Johnson

|Mar 25, 2026
Assessing respiratory status in myasthenia gravis: limited value of the MG-ADL as a standalone tool compared with spirometry in a Danish cohort.

Linda Kahr Andersen, Simone Birnbaum, Malene Missel

|Mar 16, 2026
Comorbidities and Treatment Patterns in People With Myasthenia Gravis in Denmark, Finland and Sweden: A Population-Based Observational Study.

Sari Atula, Fredrik Piehl, Ingrid Schager

|Feb 14, 2026
A roadmap for a patient-centred approach to Pompe disease management.

Benedikt Schoser, Cristina Domínguez-González, Pascal Laforet

|Jan 15, 2026
Clinical and Genotypic Spectrum of Twinkle-Related Disorders: Insights From a Multinational Cohort Study.

Piervito Lopriore, Zeynep Ünlütürk, Thomas Klopstock

Pageof 7

Frequent Collaborators

5 joint publications

Thomas Krag

4 joint publications

Jordi Díaz-Manera

4 joint publications

Peter B Kang

4 joint publications

Volker Straub